华森制药 (002907.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(华森制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 196,371,096.40189,459,493.78228,392,771.39176,285,238.90154,802,137.95172,916,396.17187,539,020.46
 营业收入(元) 196,371,096.40189,459,493.78228,392,771.39176,285,238.90154,802,137.95172,916,396.17187,539,020.46
二、营业总成本(元) 172,455,572.11181,237,617.35180,610,872.95187,847,523.88149,918,392.73165,970,718.51151,822,163.07
 营业成本(元) 83,917,634.1686,100,433.5689,843,761.0588,694,406.2968,205,145.0880,010,664.3674,438,227.92
 研发费用(元) 13,144,024.6613,198,935.4412,644,702.2828,717,561.2120,488,136.5414,762,450.7714,151,767.59
 营业税金及附加(元) 1,781,619.213,997,335.152,054,123.113,903,399.471,663,222.293,660,417.091,781,182.49
 销售费用(元) 62,483,169.4065,685,361.4468,013,058.2252,981,847.6248,049,490.0456,778,959.5052,929,378.10
 管理费用(元) 13,264,733.5015,008,927.5412,759,134.8615,971,378.6512,713,746.0112,804,540.7511,650,036.97
 财务费用(元) -2,135,608.82-2,753,375.78-4,703,906.57-2,421,069.36-1,201,347.23-2,046,313.96-3,128,430.00
  其中:利息费用(元) -348,755.50--28,442.63279,124.04468,252.48169,531.90
  其中:利息收入(元) 1,820,856.382,780,040.944,732,980.352,471,458.691,496,477.202,530,130.913,312,105.69
 资产减值损失(元) -671,140.05-329,087.39-68,066.40-229,191.02-485,066.46-106,454.70-276,738.27
 信用减值损失(元) -1,663,146.60710,598.54-2,908,718.03-51,002.963,291.401,264,724.25377,771.13
三、其他经营收益
 加:公允价值变动收益(元) 347,764.27------
 加:投资收益(元) -602,496.15-2,464,704.93-371,713.79-2,781,893.92-2,262,668.76-1,346,385.28-1,730,411.53
  其中:对联营企业和合营企业的投资收益(元) -954,346.70-2,495,496.34-371,713.79-2,587,068.82-2,262,668.76-1,346,385.28-1,893,490.14
 资产处置收益(元) ------58,474.68
 其他收益(元) 10,089,403.943,364,772.103,611,997.925,300,479.872,411,607.314,639,768.801,600,680.24
四、营业利润(元) 31,415,909.709,593,555.5448,045,398.14-5,871,839.654,550,908.7111,397,330.7335,746,633.64
 加:营业外收入(元) 127,586.0135,696.0039,446.9416,215.7165,708.3132,396.8934,324.24
 减:营业外支出(元) 70,871.17495,240.0718,612.282,863,375.33301,492.705,000.005,037.78
五、利润总额(元) 31,472,624.549,134,011.4748,066,232.80-8,718,999.274,315,124.3211,424,727.6235,775,920.10
 减:所得税费用(元) 4,110,685.032,270,367.427,714,980.733,356,857.28902,237.29163,149.775,675,378.21
六、净利润(元) 27,361,939.516,863,644.0540,351,252.07-12,075,856.553,412,887.0311,261,577.8530,100,541.89
(一)按经营持续性分类
  持续经营净利润(元) 27,361,939.516,863,644.0540,351,252.07-12,075,856.553,412,887.0311,261,577.8530,100,541.89
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 27,361,939.516,863,644.0540,351,252.07-12,075,856.553,412,887.0311,261,577.8530,100,541.89
 扣除非经常性损益后的净利润(元) 18,470,701.554,288,003.1637,264,608.09-16,652,317.611,571,080.247,243,735.2828,575,618.94
七、每股收益
 一、基本每股收益(元) 0.070.020.10-0.030.010.030.07
 二、稀释每股收益(元) 0.070.020.10-0.030.010.030.07
八、其他综合收益(元) -275,711.8173,446.2528,420.10-604,664.13-110,618.92817,760.56-55,429.94
 归属于母公司股东的其他综合收益(元) -275,711.8173,446.2528,420.10-604,664.13-110,618.92817,760.56-55,429.94
九、综合收益总额(元) 27,086,227.706,937,090.3040,379,672.17-12,680,520.683,302,268.1112,079,338.4130,045,111.95
 归属于母公司所有者的综合收益总额(元) 27,086,227.706,937,090.3040,379,672.17-12,680,520.683,302,268.1112,079,338.4130,045,111.95
公告日期 2024-10-292024-08-222024-04-292024-04-102023-10-272023-08-222023-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院